Table 2.
Thematic Analysis for FGDs and In-Depth Interviews (IDI) on Strategies to Eliminate MTCT of HIV in Addis Ababa Governmental Hospitals, Ethiopia, 2018
| Main Theme | Sub-Themes | IDI/Page No. (1 Up to 16) |
FGD/Page No. (FGD 1–6) |
|---|---|---|---|
| Effect of option B+ PMTCT | Benefits of option B+ PMTCT For the mother For the infant |
IDI-2, P2; IDI-11, P7; IDI-5, P1; IDI-13, P1 | FGD-1, p3-5; FGD-3, p5-8 |
| Side effect of option B+ PMTCT For the mother For the infant |
IDI-1, P5; IDI-2, P4; IDI-5, P2 | FGD-1, p13; FGD-2, p10 | |
| Individual/Family/ Community Factor |
HIV sero-discordant couple | IDI-1, P3, IDI-2, P2; IDI-8, P2; IDI14, P2; IDI-6, P2 | FGD-1, p5; FGD-2, p4,5; FGD-4, p3 |
| Disclosure of HIV status for sexual partner | IDI-2, P2; IDI-3, P3; IDI-7, P1; IDI-9, P1 | FGD-1, p8; FGD-2, p7; FGD-3, p7; FGD-4, p4 | |
| Community perception of option B+ PMTCT | IDI-1, P3; IDI-2, P3; IDI-3, P3 | FGD-1, p13; FGD-2, p6; FGD-3, p7 | |
| PMTCT for commercial sex worker mothers | IDI-1, P5; IDI-2, P4; IDI-5, P2 | FGD-1, p13; FGD-2, p10 | |
| Availability of HIV-free human breast milk for PMTCT | IDI-1, P3; IDI-5, P1; IDI-7, P1; IDI-11, P1; IDI-13, P2 | FGD-1, p7-8; FGD-2, p10; FGD-3, p9; FGD-4, p4 | |
| Strategies to eliminate MTCT | Develop HIV-discordant couples PMTCT counselling and disclosure guideline | IDI-1, P2, IDI-2, P3; IDI-3, P2 | FGD-1, p6; FGD-2, p5; FGD-3, p5; FGD-4, p2 |
| Develop special counselling PMTCT guideline for commercial sex worker HIV-positive mothers | IDI-3, P2; IDI-8, P3; IDI-10, P1 | FGD-1, p8; FGD-2, p8; FGD-3, p11 | |
| Use of HIV-free human breast milk (human breast milk bank) for PMTCT |
IDI-2, P2; IDI-1, P4 | FGD-1, p7,10; FGD-2, p8; FGD-3, p11 |
Abbreviations: IDI, individual in-depth interview; FGD, focus group discussion; P, page number.